Moreover, the preclinical models utilized in the study herein hold great promise for identification of biomarkers and development of novel approaches to not only prevent humoral immunity to FVIII and other therapeutic proteins but also for autoimmune diseases as well as optimization of vaccine strategies. Here, F8 is linked to autoimmune disease.